381 related articles for article (PubMed ID: 18287593)
1. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
[TBL] [Abstract][Full Text] [Related]
2. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
Robinson JG; Davidson MH
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
[TBL] [Abstract][Full Text] [Related]
6. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
[TBL] [Abstract][Full Text] [Related]
8. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
Vaverková H
Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effect of statins on atrial fibrillation after cardiac surgery.
Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M
Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529
[TBL] [Abstract][Full Text] [Related]
11. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
12. Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada.
Austin PC; Mamdani MM
Circulation; 2005 Aug; 112(9):1296-300. PubMed ID: 16116054
[TBL] [Abstract][Full Text] [Related]
13. [Ezetimib plus statin combination. A strong duo].
MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
[No Abstract] [Full Text] [Related]
14. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
Gagné C; Gaudet D; Bruckert E;
Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
[TBL] [Abstract][Full Text] [Related]
16. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].
Namal E; Sener N; Ulaş T; Akçalı Z; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2011 Dec; 11(8):703-10. PubMed ID: 22088858
[TBL] [Abstract][Full Text] [Related]
17. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin, atorvastatin, ezetimibe, and ezetimibe + simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic rats.
Bracht L; Barbosa CP; Caparroz-Assef SM; Cuman RK; Ishii-Iwamoto EL; Bracht A; Bersani-Amado CA
Fundam Clin Pharmacol; 2012 Dec; 26(6):722-34. PubMed ID: 21801201
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
